Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

Biofrontera (Nasdaq:BFRI) launched its second annual #HatsOnForAK campaign, running May 18–24, 2026, ending on Global Actinic Keratosis Awareness Day.

Rhea-AI Summary

Biofrontera (Nasdaq:BFRI) launched its second annual #HatsOnForAK campaign, running May 18–24, 2026, ending on Global Actinic Keratosis Awareness Day. This social media initiative encourages people to wear hats, post photos with dedicated hashtags, and promote awareness of actinic keratosis (AK) and comprehensive sun protection.

Argus May 13 session

-4.97% close to close Open Argus

Details

News Market Reaction – BFRI

On May 13, the day this news came out, BFRI closed 4.97% below the previous close.

Data tracked by StockTitan Argus for the May 13 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day
• This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection
• Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma¹
  
  

Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return of the Hats On Campaign for its second consecutive year. Co-founded by Biofrontera in 2025, the community-driven, social media–based initiative will run May 18–24, 2026, culminating on Global AK Awareness Day. The campaign invites participants to wear a hat, post a photo or video, and use the hashtags #HatsOnForAK, #GlobalAKDay, and #ActinicKeratosis to help raise awareness of AK and the critical role of sun protection in preventing the disease.

Building on the strong response to the inaugural 2025 campaign, this year’s Hats On Campaign sharpens its focus on prevention, encouraging Americans to adopt year-round sun-safe habits, beginning with the simple act of putting a hat on.

Actinic Keratosis (AK) is one of the most common diagnoses made by dermatologists², with an estimated global prevalence of 14%³. Caused by years of sun exposure, AK appears as rough, scaly patches on sun-exposed areas such as the face, scalp, lips, ears, forearms, chest, neck, or back of the hands, and if left untreated can develop into squamous cell carcinoma, a type of skin cancer¹.

“It’s estimated that more than 58 million Americans have one or more actinic keratoses. Recent studies have shown that the risk of AKs developing into squamous cell carcinoma increases over time, from about 9 percent within four years to about 17 percent at 10 years of follow-up. Americans can prevent AKs simply by adopting a comprehensive sun safety strategy that includes daily sunscreen use, seeking shade during peak sunlight hours, wearing sun-protective clothing and sunglasses and, of course, wearing a wide-brimmed hat.”

– Deborah S. Sarnoff, MD, President of The Skin Cancer Foundation.

Join the Campaign

To take part, follow Biofrontera on social media and beginning May 18, share a photo wearing your favorite hat and use the hashtags listed above in your post. The Skin Cancer Foundation will also highlight AK content on its channels in the days surrounding Global AK Awareness Day.

About Biofrontera Inc.

Biofrontera is a U.S.-based biopharmaceutical company specializing in the treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination AMELUZ^® with the RhodoLED^® lamp series for PDT of Actinic Keratosis, pre-cancerous skin lesions which may progress to invasive skin cancers¹. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate-to-severe acne. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and X.

Contact:
Media Relations
Leslie Hopkins
Lhopkins@BFINC.com

¹ Skin Cancer Foundation. Actinic Keratosis Overview. Available at: https://www.skincancer.org/skin-cancer-information/actinic-keratosis/

² Wilmer EN, Gustafson CJ, Ahn CS, Davis SA, Feldman SR, Huang WW. Most common dermatologic conditions encountered by dermatologists and nondermatologists. Cutis. 2014;94(6):285-92.

³ Christopher D George, Truelian Lee, Loes M Hollestein, Maryam M Asgari, Tamar Nijsten. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. British Journal of Dermatology, Volume 190, Issue 4, April 2024, Pages 465–476.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Biofrontera's 2026 #HatsOnForAK campaign for actinic keratosis (BFRI)?

The 2026 #HatsOnForAK campaign is a social media initiative to raise awareness of actinic keratosis and sun safety. According to Biofrontera, participants wear hats, share photos, and use specific hashtags to highlight prevention and year-round sun-protective habits.

When does Biofrontera's 2026 Hats On campaign for actinic keratosis (BFRI) take place?

Biofrontera’s second annual Hats On campaign runs from May 18–24, 2026, culminating on Global Actinic Keratosis Awareness Day. According to Biofrontera, the company uses this week to encourage sun-safe behaviors and online engagement around actinic keratosis prevention.

How can people participate in Biofrontera's #HatsOnForAK 2026 campaign (BFRI)?

People can join by following Biofrontera on social media, wearing a favorite hat, and posting a photo or video. According to Biofrontera, participants should use the hashtags #HatsOnForAK, #GlobalAKDay, and #ActinicKeratosis to help spread awareness of AK and sun protection.

Why is Biofrontera focusing on actinic keratosis awareness in 2026 (BFRI)?

Biofrontera highlights actinic keratosis because it is common and can progress to squamous cell carcinoma if untreated. According to Biofrontera, an estimated 58 million Americans have AK, underscoring the need for education on prevention and early management.

What sun safety measures does Biofrontera promote in the 2026 Hats On campaign (BFRI)?

The campaign promotes comprehensive sun safety, including daily sunscreen, shade during peak sun, sun-protective clothing, sunglasses, and wide-brimmed hats. According to Biofrontera, these habits can help prevent actinic keratosis and reduce long-term risk of progression to skin cancer.

How common is actinic keratosis globally, as highlighted in Biofrontera's 2026 campaign (BFRI)?

Actinic keratosis is described as one of the most common dermatology diagnoses, with an estimated global prevalence of 14%. According to Biofrontera, this high prevalence supports the need for public awareness initiatives like the Hats On campaign.